Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShires Inc. Regulatory News (SHRS)

  • This share is currently suspended. It was suspended at a price of 302.00
  • There is currently no data for SHRS

Half-year Financial Report

24 Nov 2025 07:00

RNS Number : 6174I
Shires Income PLC
24 November 2025
 

SHIRES INCOME PLC

 

HALF YEARLY FINANCIAL REPORT

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

Legal Entity Identifier (LEI): 549300HVCIHNQNZAYA89

 

INVESTMENT OBJECTIVE

The Company's investment objective is to provide shareholders with a high level of income, together with the potential for growth of both income and capital from a diversified portfolio substantially invested in UK equities but also in preference shares, convertibles and fixed income securities.

 

BENCHMARK

The Company's benchmark is the FTSE All-Share Index (total return).

 

 

Performance Highlights

Net asset value per Ordinary share total returnA ​

​

Share price total returnA ​

Six months ended 30 September 2025 ​

​

Six months ended 30 September 2025 ​

+15.0% ​

​

+12.7% ​

Year ended 31 March 2025

+9.4%

​

Year ended 31 March 2025

+22.4%

​

​

​

​

​

Benchmark index total return

​

​

Earnings per Ordinary share (revenue)

​

Six months ended 30 September 2025

​

​

Six months ended 30 September 2025

​

+11.6% ​

​

9.56p ​

Year ended 31 March 2025

+10.5%

​

Six months ended 30 September 2024

8.15p

​

​

​

​

​

Dividend yieldA

​

​

Discount to net asset valueA

​

As at 30 September 2025

​

​

As at 30 September 2025

​

5.6% ​

​

5.7% ​

As at 31 March 2025

5.8%

​

As at 31 March 2025

3.7%

A Considered to be an Alternative Performance Measure. ​ ​ ​ ​

Financial Calendar and Financial Highlights

Financial Calendar

Expected payment dates of quarterly dividends

30 January 2026

30 April 2026

31 July 2026

30 October 2026

Financial year end

31 March 2026

Expected announcement of results for year ended 31 March 2026

May 2026

Annual General Meeting

July 2026

Financial Highlights

​

30 September 2025

31 March 2025

% change

Total assets (ÂŁ'000)

136,294

125,686

+8.4

Shareholders' funds (ÂŁ'000)

117,313

106,711

+9.9

Net asset value per share

295.78p

265.23p

+11.5

Share price (mid-market)

279.00p

255.50p

+9.2

Discount to net asset value (cum-income)A

5.7%

3.7%

​

Dividend yieldA

5.6%

5.8%

​

Net gearingA

15.1%

16.5%

​

Ongoing charges ratioA

1.02%

1.00%

​

A Considered to be an Alternative Performance Measure.  ​ ​ ​

Performance (total return)

​

Six months ended

Year ended

Three years ended

Five years ended

​

30 September 2025

30 September 2025

30 September 2025

30 September 2025

Net asset valueA

+15.0%

+17.8%

+46.8%

+69.5%

Share priceA

+12.7%

+20.5%

+45.3%

+73.5%

FTSE All-Share Index

+11.6%

+16.2%

+50.0%

+84.1%

A Considered to be an Alternative Performance Measure.. ​ ​ ​ ​

All figures are for total return and assume reinvestment of net dividends excluding transaction costs. ​ ​ ​ ​

 

For further information, please contact:

 

 

Ben Heatley

Aberdeen

ben.heatley@aberdeenplc.com

Chairman's Statement

Highlights

- Net Asset Value ("NAV") total return of 15.0%.

- Share price total return of 12.7%.

- Dividend yield of 5.6%. 

Review of the Period

I am pleased to report a period of strong performance, with the Company continuing to deliver on its objective of providing a high level of income and capital growth.

The Net Asset Value ("NAV") total return for the six month period to 30 September 2025 was 15.0%. This compares favourably to a wider market return of 11.6% as measured by the FTSE All-Share Index. The share price total return was 12.7%. It is pleasing that we have seen a five year share price total return of 73.5%, with some growth in dividends paid to shareholders, as well as more stability in the share price over the last two years, partly achieved by using share buyback powers.

At the start of the period, trade tariffs introduced by the US government caused equity markets to fall but they recovered as tariffs were negotiated and revised. However, the net result remains one of additional cost for businesses that export to the US. Markets recovered with the prospect of interest rate reductions and strong earnings growth globally. The UK market performed well despite an economic backdrop that continues to be challenging, not helped by uncertainty on UK fiscal circumstances.

The total return from the equity holdings within the portfolio was 15.6%. This return was driven by good stock selection, with positive contributions from several of the holdings. The total return from the distinct portfolio of preference shares was lower, at 5.1%, but in line with expectations as these investments have the performance attributes of fixed interest instruments. The preference share holdings represented 17.1% of the portfolio at the end of the period and are a differentiating factor of the Company, providing a reliable source of income at a yield above that of the benchmark index. 

A detailed review of performance and investment activity is contained in the Investment Manager's Review.

Earnings and Dividends

The revenue earnings per share for the period were 9.56p, an increase of 17.3% compared to the equivalent period last year. Companies within the portfolio have continued to generate solid earnings and dividend growth. The Company also benefited from the receipt of a special dividend relating to the tender of one of its preference share holdings.

A first interim dividend of 3.40p per Ordinary share in respect of the year ending 31 March 2026 was paid on 31 October 2025 (2025: first interim dividend 3.20p). The Board is declaring a second interim dividend of 3.45p per Ordinary share, payable on 30 January 2026 to shareholders on the register at close of business on 5 January 2026. Subject to unforeseen circumstances, it is proposed to pay a further interim dividend of 3.45p per Ordinary share and a final dividend of at least 5.20p per share, being the level of final dividend paid last year. This would result in a total dividend for the year of at least 15.50p per share which represents a dividend yield of 5.6% based on the share price of 279p at the end of September. The aim was to pay three interim dividends of 3.45p per share but due to an administrative oversight the first interim dividend was announced and paid at a rate of 3.40p per share rather than at a rate of 3.45p per share, which will be rectified in the payment made in the final dividend.

The Board considers the Company's high level of dividend to be one of its key attractions and recognises that, in the current economic environment, there is likely to be a continuing demand for an attractive and reliable level of income. We have a very high proportion of our investors invested through retail platforms and many of those will be 'tax protected' in ISAs or SIPPs. Some will have elected for periodic saving into the shares of the Company and some for reinvestment of dividends, both historically good ways of obtaining a long-term return on investments made in income funds, especially if held through ISAs.

Discount and Share Buy Backs

At the end of the period, the discount of the share price to the NAV was 5.7%, slightly wider than the discount of 3.7% at the start of the period reflecting an average discount of 4.4% over the period.

In accordance with the share buy-back authority provided by shareholders, the Company bought back 569,354 Ordinary shares during the period (1.4% of the issued share capital) at a cost of ÂŁ1.5 million and this provided a small enhancement to NAV for continuing shareholders. All shares bought back are held in treasury. Since commencing share buy backs in March 2024, at the date of this Report the Company has bought back an aggregate of 2.1 million shares (5.0% of the issued share capital) and the implementation of buy backs has had positive effect on the share price rating which had drifted at one point to a double digit discount.

Corporate

In the last few years, the Board has worked hard with Aberdeen to try and find ways of reducing operating costs, finding fresh demand for the Company's shares and providing for secondary market liquidity. As a result, the Company combined successfully with abrdn Smaller Companies Investment Trust in December 2023, has applied share buy backs where necessary and continues to have a largely retail held register. The market and demand background for closed-ended funds with listed equity mandates has not been propitious. The Board firmly believes that high income from UK listed equities can best be provided by a closed-ended vehicle that uses gearing effectively, allocates expenses to capital, and uses reserves to sustain and grow income, and can avoid volatility in its share price - which is what the Board and Manager will continue to try and provide through Shires Income.

Gearing

The Company has a ÂŁ20 million loan facility of which ÂŁ19 million was drawn down at the period end. Net of cash, this represented gearing of 15.1% on 30 September, compared to 16.5% at the start of the period. The weighted average borrowing cost at the period-end was 4.7% (31 March 2025: 4.9%) and the gearing provided a positive contribution to performance during the period.

The Board monitors the level of gearing regularly. Strategically, we take the view that the borrowings are notionally invested in the less volatile fixed income part of the portfolio which generates a higher and more secure level of income, giving the Investment Manager greater scope to invest in a range of equity shares with lower yields and higher growth prospects. The Board believes that this combination puts the Company in the best position to achieve a high and potentially growing level of dividend and to deliver some capital appreciation for shareholders - as has been the case in the past. The Board and Manager continue to review borrowing facilities and the cost thereof to ensure that the Company can benefit from a positive geared return for its shareholders.

Outlook

The UK economic picture remains a challenging one, with growth limiting factors such as the cost of servicing public debt and increasing welfare costs. However, with the prospect of interest rates falling, there is the potential for economic conditions to improve. As always, there is uncertainty regarding the measures that will be introduced in the Budget on 26 November and the impact that these will have on companies and individuals.

Notwithstanding these uncertainties and the strong portfolio returns generated during the first half of the financial year, the Investment Manager considers that the UK equity market continues to be attractively valued compared to other global markets. When combined with the good earnings and dividend potential from the companies in the portfolio, the Board is confident that the Company is well placed to continue to deliver its investment objective in terms of both income and capital growth.

 

Robin ArchibaldChairman21 November 2025

Investment Manager's Review

Market Background

Financial markets had a positive six-month period, with equities continuing to deliver high returns. Those returns have come despite elevated levels of geopolitical uncertainty. At the start of the period, the US administration introduced much higher tariffs on imports in the so called 'Liberation Day' announcement. This rattled markets in the short term, sending global equities down by 12% in two weeks. Since that point, there has been continued negotiation and revision of tariff proposals, and, while the direction of travel has been positive, the costs for importers to the US remain significantly higher than previously with an average tariff rate of 15%. The subsequent strength of global equities has surprised many, but the prospect of falling interest rates globally, combined with resilient earnings growth and lower taxation in the US, has propelled stocks to new highs. While the large-cap US listed technology companies have continued to be strong performers, we have seen value names globally pulled higher in the rally, and European and UK markets have performed well.

Despite the initial expectation that tariffs would prove to be inflationary for the US consumer, we are yet to see that impact. This has allowed the Federal Reserve (the "Fed") to decrease interest rates modestly, with a quarter point cut to 4.25% in September and to 4.0% in October. There is still potential for the inflationary effect to come through, however, given the lag before imported orders reach the consumer. Despite that, we expect continued cuts to the Fed rate in the next year. The Bank of England has also been able to reduce rates, with the official bank rate at 4.0%, down from 4.5% at the end of March. Central banks in both countries continue to balance inflation against the signs of a weakening labour market. Although unemployment has not risen significantly, vacancies are reducing and there are signs of the market being looser than we have seen for some time.

For the UK specifically, economic growth remains lacklustre and the current account deficit a concern. Policies introduced in late 2024, raising employer National Insurance contributions and the living wage, have placed a cost burden on companies. At the same time, higher costs of debt and a failure to reform social spending have limited headroom for the government. That has created pressure on the Chancellor's budget in November, and the long lead into this event has created an overhang on UK domestically focused companies. In Europe, markets have been boosted by the relaxation of debt limits in Germany. This has allowed a re-investment into European defence capability and we expect fiscal policy to feed through into better corporate earnings growth. Offsetting this, France has undergone a period of continued political instability and a budgetary deficit even worse than that of the US or UK.

Commodities have been mixed, with a weaker oil price but strength in mined commodities. Precious metals, most notably gold, have been strong as investors search for stores of value. Other metals such as copper, have also moved higher on continued demand growth and downward supply revisions. 

Investment Performance

It was a strong period for the portfolio, with a NAV total return of 15.0%. This is a strong absolute return for the six month period and compares positively with the FTSE All-Share Index benchmark return of 11.6%. Relative performance was driven by stock selection, most notably in the energy and industrial sectors. The Company's exposure to preference shares and fixed income securities detracted from returns on a relative basis, but this is as we would expect in a strongly rising market and was more than compensated for by the outperformance of the equity portfolio. By sector, industrials (+35%), financials (+18%) and utilities (+13%) were notable sources of strength. Energy (+3%), consumer discretionary (+3%) and healthcare (+2%) were relatively weak, although no sector produced a negative return over the period.

On an individual stock basis, there were good returns from our conviction position in the UK construction contractors. Kier returned 79%, Balfour Beatty 52% and Morgan Sindall 38%. These companies have performed well for several years now but remain well valued and have a robust outlook as the UK invests in power, water and infrastructure.

The financials sector also delivered continued share price performance as banks benefited from volume growth and yield curves which remain supportive. OSB's shares returned 35% and Close Brothers returned 78% after the company benefitted from a better-than-expected outcome from the FCA inquiry into historic motor finance. Insurance companies Chesnara (+28%) and Aviva (+32%) also performed well, as did asset manager M&G (+31%).

We had few disappointments during the period. In some cases, we have bought into companies after a period of weakness and perhaps been a little early. Greggs fell 11% after purchase, Victrex 11%, Midwich 10% and Pets at Home 21%. All are companies we have added after a period of significant share price weakness and where we see potential for a turnaround over the next three-to-five-year period. Timing the bottom is difficult, but our view on these companies remains that expectations are low and there is more upside risk than downside. One benefit of a closed end structure is that we can be patient for the turnaround.

The one genuine disappointment was Wood Group, which saw debt increase, the announcement of an inquiry into historic accounting and the departure of its CFO. As it stands, the company is the subject of a bid from a private peer, so could yet deliver a positive outcome, but its shares are currently not trading and we have prudently marked the value of the holding to zero.

Portfolio Activity

April was a quiet month for trading. The market volatility through the month was extremely high, and changes to US policy on a daily basis caused a high degree of variability in share prices. In this environment it is sometimes better not to do too much - what looks like the right trade one day may turn out to be the wrong one the next and we try and hold positions we are happy to retain for the long term. At the start of May we sold out of Convatec. This is a very well-run company which has performed well, but with the yield compressed to below 2% we see other positions more suited to the goals of the Company. The proceeds were reinvested in Informa, which is a commercial information and exhibition business and has been a long-term compounder with a track record of dividend growth.

Following a bid for Assura, we sold out of the position and switched into other high conviction UK real estate holdings; SafeStore, Sirius Real Estate and London Metric. We also sold the position in Engie after a few weeks of holding the shares. In that time the share price had risen and we had collected the annual dividend, so this was a chance to reallocate capital to other ideas.

We bought back into Greggs, having sold out in June last year. Since that time, the shares had underperformed the benchmark by approximately 40%, creating a chance to buy back into what remains a high-quality retailer at a more reasonable price. To fund the purchase, we sold out of Dunelm. This was another short holding period, as its shares had delivered a 30% return since purchase three months beforehand, and had hit our target price. We also bought into audio-visual supplier Midwich, which has struggled cyclically but has long term recovery potential. It is a founder-led business with a great track record which we think will get back to growth once the cycle improves.

We sold out of the holding in 4Imprint. The shares had bounced post tariff introduction, but it remains a cyclical business. Given the weaker outlook for the US Dollar, the appeal of overseas earnings is also lower for now. We used the proceeds to buy into UK retailer Pets at Home which we consider is valued attractively given the strength of its vet business and with potential for the retail business to improve after a more difficult period.

The tender process for the General Accident preference shares held in the portfolio completed in June. We saw the tender price as fair, giving a 5.6% yield at the sale price. The proceeds were primarily used to add to the position in the Nationwide 10.25% perpetual debt, which had a yield of 7.8% at purchase, a nice uplift to income.

Also in June, we took the decision to exit ASML for now. There is no debate that this is one of the highest quality companies in the market, with seemingly insurmountable barriers to competition in a structurally growing end market. However, we saw some risk to earnings estimates in 2026/27, and with a low dividend yield we saw other opportunities that fit the objectives of the Company more closely. The proceeds were used to introduce Victrex, a specialist chemical manufacturer which has faced a cyclical downturn for some time but is starting to see signs of improvement in its higher margin healthcare end market and recently signed a material order to supply material for subsea piping.

At the end of July we bought back into IT distributor Bytes Technology, having sold the position in November. The shares pulled back recently on a weaker trading update, but we saw this as backward looking and reflecting historic changes to partner incentive structures. The business remains well positioned as one of the largest software sellers in the UK, with a growth end market and strong client relations. The valuation, with a 5%+ dividend yield, offers decent upside and it acts as a genuine diversifier in the portfolio.

Finally, we added one new holding in September, starting a position in Hilton Food. The company supplies meat and fish to UK and international supermarkets and has built a track record of compound growth over time as it grows in scale, with a contract structure that protects it from pricing fluctuations. At the start of September, the shares fell by around 20% following a profit warning for this year, as it has had to build fish inventory due to supply shortages. We see this as a short-term impact and a chance to acquire a position in a good quality company with a dividend yield now over 5%. Hilton is a company we've been watching for a while and it is a useful diversifier in the portfolio, adding to consumer staples where it is hard to find businesses of sufficient quality and yield to fit our requirements.

Investment Income

The revenue earnings per share for the period were 9.56p, which compares to 8.15p for the equivalent period last year. Over the period, the portfolio continued to deliver income growth and the Company also benefited from the receipt of a special dividend relating to the tender of the General Accident preference shares. Although there has been a continued trend for companies to allocate more capital to share buybacks over dividend growth in recent years, there is still strong dividend growth available from companies with growing cashflows. A mild headwind to income generation over the period was the weaker US Dollar, given a number of companies pay dividends denominated in Dollars.

Outlook

On a global basis, our outlook is for a continued 'late-cycle' macro environment, in which the US economy is slowing but avoids recession, policy rates are cut and the Federal Reserve resumes easing, a slowing nominal growth environment in China but with ongoing policy support and the increasing emergence of 'AI winners' in its corporate sector, and an ongoing interest rate cutting cycle across many emerging markets as the focus shifts from containing inflation to supporting growth.

Certainly, there are considerable economic and geopolitical risks around these expectations. The deterioration in the US labour market could morph into a broader downturn and recession amid 'stall speed' dynamics, although a mini-cyclical pickup now that peak tariff uncertainty appears to have passed is also possible. Political interference at the Fed could de-anchor inflation expectations and eventually trigger a bond market rout. Alternatively, AI-driven productivity growth could see a sustained supply-side expansion in coming years. This creates a supportive environment for continued strength in equities, but the risk-reward is more balanced than for some time. High valuations and an extreme level of concentration, most notably in the US equity market, mean that any downturn could be meaningful.

In the UK, government finances remain a concern, with low productivity and increasing fiscal burden limiting growth. The increased cost of debt and lack of reform to social spending means the ability of the government to change the path is limited. However, this picture can change quickly in our view. Slowing inflation into the year-end would give the Bank of England clearance to reduce interest rates more rapidly than expected. This would have the double impact of both stimulating growth but also reducing government borrowing costs. We should not rule out an economic picture that looks more optimistic in six months' time.

We see significant sources of value in the UK equity market. It remains well valued compared to other global markets, and although it lacks a significant technology sector that does not mean there is no growth from a wide range of high quality companies. Distribution yields are also highly attractive, with the combination of dividends and buybacks at the highest level amongst all major markets. Those distributions also look safe, with payout ratios still well below pre-Covid levels.

Our aim is to identify those companies with long term potential which are currently undervalued by the market. The current degree of scepticism of UK mid-cap and domestically focussed companies means that this is a particularly rich hunting ground and we retain a high level of optimism for future returns.

 

Iain PyleAberdeen21 November 2025

Interim Management Statement

Directors' Responsibility Statement

The Directors are responsible for preparing the Half Yearly Financial Report in accordance with applicable law and regulations. The Directors confirm that to the best oftheir knowledge:

- the condensed set of financial statements within the Half Yearly Financial Report has been prepared in accordance with IAS 34 'Interim Financial Reporting'; and

- the Interim Board Report (constituting the Interim Management Report) includes a fair review of the information required by rules 4.2.7R of the Disclosure Guidance and Transparency Rules (being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements and a description of the principal risks and uncertainties for the remaining six months of the financial year) and 4.2.8R (being related party transactions that have taken place during the first six months of the financial year and that have materially affected the financial position of the Company during that period; and any changes in the related party transactions described in the last Annual Report that could so do).

Principal and Emerging Risks and Uncertainties

The Board regularly reviews the principal and emerging risks and uncertainties faced by the Company together with the mitigating actions it has established to manage the risks. These are set out within the Strategic Report contained within the Annual Report for the year ended 31 March 2025 and comprise the following risk headings:

- Strategic objectives and investment policy

- Investment performance

- Failure to maintain, and grow the dividend over the longer term

- Share price and shareholder relations

- Gearing

- Accounting and financial reporting

- Regulatory

- Operational

- The Board

- Exogenous risks such as health, social, financial, economic, climate and geo-political

In addition to these risks, various global conflicts and other geo-political tensions continue to present exogenous risks as does the recent introduction of trade tariffs and the impact that has on global trade and financial markets. The impending UK Budget, fiscal constraints and elevated global market valuations, with high levels of concentration, also provide uncertainties for a UK equity investment company.

In all other respects, the Company's principal and emerging risks and uncertainties have not changed materially since the date of the Annual Report and are not expected to change materially for the remaining six months of the Company's financial year.

Going Concern

The Company's assets consist mainly of equity shares in companies listed on the London Stock Exchange. The Board has performed stress testing and liquidity analysis on the portfolio and considers that, in the absence of unforeseen circumstances, the majority of the Company's investments are realisable within a relatively short timescale.

The Board has set limits for borrowing and regularly reviews actual exposures, cash flow projections and compliance with banking covenants, including the headroom available. The Company has a ÂŁ20 million loan facility which is due to mature in April 2027. ÂŁ9 million of this amount is drawn down on a short-term basis through a revolving credit facility and can be repaid without incurring any financial penalties.

Having taken these factors into account, the Directors believe that the Company has adequate resources to continue in operational existence for the foreseeable future and has the ability to meet its financial obligations as they fall due for the period to 30 November 2026, which is at least twelve months from the date of approval of this Report. For these reasons, they continue to adopt the going concern basis of accounting in preparing the financial statements.

 

On behalf of the BoardRobin ArchibaldChairman21 November 2025

Investment Portfolio - Equities

As at 30 September 2025

​

​

​

Market

Total

​

value

portfolio

​

ÂŁ'000

%

Shell

4,265

3.2

Morgan Sindall

4,218

3.1

AstraZeneca

3,931

2.9

HSBC

3,863

2.9

Chesnara 

3,841

2.9

Balfour Beatty

3,295

2.4

National Grid

3,194

2.4

Diversified Energy

3,167

2.3

M&G

3,051

2.3

Sirius Real Estate

2,995

2.2

Ten largest investments

35,820

26.6

Kier

2,937

2.2

Rio Tinto

2,920

2.2

Imperial Brands

2,867

2.1

Lloyds Banking

2,860

2.1

SSE

2,750

2.0

Telecom Plus

2,739

2.0

Energean

2,528

1.9

Safestore

2,489

1.9

Barclays

2,477

1.9

Anglo American

2,342

1.7

Twenty largest investments

62,729

46.6

Standard Chartered

2,322

1.7

Taylor Wimpey

2,319

1.7

Reckitt Benckiser Group

2,293

1.7

Intermediate Capital

2,290

1.7

Intesa Sanpaolo

2,078

1.6

Ashmore

2,019

1.5

Inchcape

1,981

1.5

Melrose Industries

1,887

1.4

Drax

1,797

1.3

Aviva

1,796

1.3

Thirty largest investments

83,511

62.0

Conduit Holdings

1,764

1.3

Hunting

1,725

1.3

LondonMetric

1,720

1.3

Serica Energy

1,692

1.2

MONY Group

1,684

1.2

Victrex

1,669

1.2

Hilton Food

1,610

1.2

ME Group

1,453

1.1

OSB

1,423

1.1

Greggs

1,345

1.0

Forty largest investments

99,596

73.9

Bytes Technology

1,285

1.0

Hollywood Bowl

1,284

0.9

Bodycote

1,282

0.9

Pets at Home

1,214

0.9

Informa

1,168

0.9

Midwich

1,163

0.9

IP Group

1,100

0.8

RS

1,048

0.8

Gaztransport Et Technigaz

1,039

0.8

Close Brothers

852

0.6

Fifty largest investments

111,031

82.4

Smurfit Westrock

697

0.5

Wood Group A

-

0.0

Total equity investments

111,728

82.9

​

​

​

A Shares are temporarily suspended on the London Stock Exchange effective 1 May 2025.

​

​

Investment Portfolio - Other Investments

As at 30 September 2025 ​ ​

​

Market

Total

​

value

portfolio

​

ÂŁ'000

%

Preference shares and Fixed Interest investmentsA

​

​

Ecclesiastical Insurance Office 8.625%

6,510

4.8

Nationwide 10.25%

5,966

4.4

Santander 10.375%

4,906

3.7

Standard Chartered 8.25%

3,485

2.6

Lloyds Bank 11.75%

1,052

0.8

R.E.A Holdings 9%

798

0.6

Standard Chartered 7.375%

290

0.2

Total preference shares and fixed interest investments

23,007

17.1

Total equity investments

111,728

82.9

Total investments

134,735

100.0

A None of the preference shares and fixed interest investments listed above have a fixed redemption date. ​ ​

 

Distribution of Assets and Liabilities

​

Valuation at ​

Movement during the period ​ ​

Valuation at ​

​

31 March 2025 ​

Purchases

Sales

Gains

30 September 2025 ​

​

ÂŁ'000

%

ÂŁ'000

ÂŁ'000

ÂŁ'000

ÂŁ'000

%

Listed investments

​

​

​

​

​

​

​

Equities

99,870

93.6

20,446

(20,718)

12,130

111,728

95.2

Preference shares and Fixed Interest investments

23,473

22.0

1,037

(1,560)

57

23,007

19.6

Total investments

123,343

115.6

21,483

(22,278)

12,187

134,735

114.8

Current assets

2,980

2.8

​

​

​

2,200

1.9

Current liabilities

(637)

(0.6)

​

​

​

(641)

(0.5)

Non-current liabilities

(18,975)

(17.8)

​

​

​

(18,981)

(16.2)

Net assets

106,711

100.0

​

​

​

117,313

100.0

​

​

​

​

​

​

​

​

Net asset value per Ordinary share

265.23p

​

​

​

​

295.78p

​

 

Condensed Statement of Comprehensive Income

​

​

 30 September 2025  ​ ​

 30 September 2024  ​ ​

31 March 2025  ​ ​

​

​

 (unaudited)  ​ ​

 (unaudited)  ​ ​

 (audited)  ​ ​

​

​

 Revenue

 Capital

 Total

 Revenue

 Capital

 Total

 Revenue

 Capital

 Total

​

Note

 £'000

 £'000

 £'000

 £'000

 £'000

 £'000

 £'000

 £'000

 £'000

Gains on investments at fair value

​

-

12,187

12,187

-

4,253

4,253

-

4,472

4,472

Currency gains/(losses)

​

-

8

8

-

(18)

(18)

-

(5)

(5)

​

​

​

​

​

​

​

​

​

​

​

Investment income

​

​

​

​

​

​

​

​

​

​

Dividend income

​

4,359

-

4,359

3,911

-

3,911

7,165

-

7,165

Interest income

​

2

-

2

8

-

8

8

-

8

Other income

​

37

-

37

92

-

92

92

-

92

Money market interest

​

16

-

16

14

-

14

31

-

31

​

​

4,414

12,195

16,609

4,025

4,235

8,260

7,296

4,467

11,763

​

​

​

​

​

​

​

​

​

​

​

Expenses

​

​

​

​

​

​

​

​

​

​

Management fee

​

(140)

(210)

(350)

(124)

(187)

(311)

(261)

(392)

(653)

Administrative expenses

​

(235)

-

(235)

(232)

-

(232)

(428)

(19)

(447)

Finance costs

​

(189)

(283)

(472)

(206)

(308)

(514)

(402)

(603)

(1,005)

​

​

(564)

(493)

(1,057)

(562)

(495)

(1,057)

(1,091)

(1,014)

(2,105)

Profit before taxation

​

3,850

11,702

15,552

3,463

3,740

7,203

6,205

3,453

9,658

​

​

​

​

​

​

​

​

​

​

​

Taxation

2

(42)

-

(42)

(92)

(19)

(111)

(108)

-

(108)

Profit attributable to equity holders

​

3,808

11,702

15,510

3,371

3,721

7,092

6,097

3,453

9,550

​

​

​

​

​

​

​

​

​

​

​

Earnings per Ordinary share (pence)

4

9.56

29.38

38.94

8.15

8.99

17.14

14.80

8.38

23.18

​

​

​

​

​

​

​

​

​

​

​

The Company does not have any income or expense that is not included in the profit for the period, and therefore the profit for the period is also the "Total comprehensive income for the period", as defined in IAS 1 (revised). ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

The total column of this statement represents the Statement of Comprehensive Income of the Company, prepared in accordance with UK adopted International Accounting Standards. The revenue and capital columns are supplementary to this and are prepared under guidance published by the Association of Investment Companies.  ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

All items in the above statement derive from continuing operations. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

The accompanying notes are an integral part of the financial statements. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

Condensed Balance Sheet

​

​

As at

As at

As at

​

​

30 September 2025

30 September 2024

31 March 2025

​

​

(unaudited)

(unaudited)

(audited)

​

Note

ÂŁ'000

ÂŁ'000

ÂŁ'000

Non-current assets

​

​

​

​

Equities

​

111,728

101,815

99,870

Preference shares and Fixed Interest investments

​

23,007

25,237

23,473

Securities at fair value

​

134,735

127,052

123,343

​

​

​

​

​

Current assets

​

​

​

​

Accrued income and prepayments

​

952

1,230

1,658

Cash and cash equivalents

​

1,248

901

1,322

​

​

2,200

2,131

2,980

​

​

​

​

​

Creditors: amounts falling due within one year

​

​

​

​

Trade and other payables

​

(641)

(475)

(637)

​

​

(641)

(475)

(637)

Net current assets

​

1,559

1,656

2,343

Total assets less current liabilities

​

136,294

128,708

125,686

​

​

​

​

​

Non-current liabilities

​

​

​

​

Revolving credit facilityA

​

(9,000)

(9,000)

(9,000)

Loan due in more than one year

​

(9,981)

(9,969)

(9,975)

Net assets

​

117,313

109,739

106,711

​

​

​

​

​

Share capital and reserves

​

​

​

​

Called-up share capital

6

21,166

21,166

21,166

Special reserve

1

49,952

49,952

49,952

Capital reserve

7

38,217

31,172

28,055

Revenue reserve

​

7,978

7,449

7,538

Equity shareholders' funds

​

117,313

109,739

106,711

​

​

​

​

​

Net asset value per Ordinary share (pence)

5

295.78

265.14

265.23

​

​

​

​

​

A The prior interim balance for the revolving credit facility has been reclassified from current to non-current liabilities. ​ ​ ​ ​

The accompanying notes are an integral part of the financial statements. ​ ​ ​ ​

Condensed Statement of Changes in Equity

Six months ended 30 September 2025 (unaudited) ​ ​ ​ ​ ​ ​

​

​

Share

​

​

​

​

​

Share

premium

Special

Capital

Revenue

​

​

capital

account

reserve

reserve

reserve

Total

​

ÂŁ'000

ÂŁ'000

ÂŁ'000

ÂŁ'000

ÂŁ'000

ÂŁ'000

As at 31 March 2025

21,166

-

49,952

28,055

7,538

106,711

Repurchase of Ordinary shares into treasury

-

-

-

(1,540)

-

(1,540)

Profit for the period

-

-

-

11,702

3,808

15,510

Equity dividends

-

-

-

-

(3,368)

(3,368)

As at 30 September 2025

21,166

-

49,952

38,217

7,978

117,313

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Six months ended 30 September 2024 (unaudited) ​ ​ ​ ​ ​ ​

​

​

Share

​

​

​

​

​

Share

premium

Special

Capital

Revenue

​

​

capital

account

reserve

reserve

reserve

Total

​

ÂŁ'000

ÂŁ'000

ÂŁ'000

ÂŁ'000

ÂŁ'000

ÂŁ'000

As at 31 March 2024

21,166

49,952

-

27,451

7,388

105,957

Cancellation of share premium account (note 1)

-

(49,952)

49,952

-

-

-

Profit for the period

-

-

-

3,721

3,371

7,092

Equity dividends

-

-

-

-

(3,310)

(3,310)

As at 30 September 2024

21,166

-

49,952

31,172

7,449

109,739

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Year ended 31 March 2025 (audited) ​ ​ ​ ​ ​ ​

​

​

Share

​

​

​

​

​

Share

premium

Special

Capital

Revenue

​

​

capital

account

reserve

reserve

reserve

Total

​

ÂŁ'000

ÂŁ'000

ÂŁ'000

ÂŁ'000

ÂŁ'000

ÂŁ'000

As at 31 March 2024

21,166

49,952

-

27,451

7,388

105,957

Repurchase of Ordinary shares into treasury

-

-

-

(2,849)

​

(2,849)

Cancellation of share premium account (note 1)

-

(49,952)

49,952

-

-

-

Profit for the period

-

-

-

3,453

6,097

9,550

Equity dividends

-

-

-

-

(5,947)

(5,947)

​

​

​

​

​

​

​

As at 31 March 2025

21,166

-

49,952

28,055

7,538

106,711

​

​

​

​

​

​

​

The capital reserve at 30 September 2025 is split between realised gains of £23,824,000 and unrealised gains of £14,393,000 (30 September 2024: realised gains of £28,291,000 and unrealised gains of £2,881,000; 31 March 2025: realised gains of £24,383,000 and unrealised gains of £3,672,000). ​ ​ ​ ​ ​ ​

The Company's reserves available to be distributed by way of dividends or buybacks include the special reserve, the revenue reserve and the realised element of the capital reserve amounting to £81,754,000 (30 September 2024 - £85,692,000; 31 March 2025 - £81,873,000). ​ ​ ​ ​ ​ ​

Condensed Cash Flow Statement

​

Six months ended

Six months ended

Year ended

​

30 September 2025

30 September 2024

31 March 2025

​

(unaudited)

(unaudited)

(audited)

​

ÂŁ'000

ÂŁ'000

ÂŁ'000

Net cash inflow from operating activities

​

​

​

Dividend income received

5,091

4,461

7,183

Interest received from money market funds

16

14

31

Bank interest received

(8)

8

8

Management fee paid

(341)

(266)

(439)

Other cash expenses

(214)

(278)

(483)

Cash generated from operations

4,544

3,939

6,300

​

​

​

​

Interest paid

(466)

(516)

(1,008)

Overseas tax paid

(51)

(102)

(119)

Net cash inflow from operating activities

4,027

3,321

5,173

​

​

​

​

Cash flows from investing activities

​

​

​

Purchases of investments

(21,483)

(33,346)

(58,872)

Sales of investments

22,278

32,579

62,170

Net cash inflow/(outflow) from investing activities

795

(767)

3,298

​

​

​

​

Cash flows from financing activities

​

​

​

Equity dividends paid

(3,368)

(3,310)

(5,947)

Repurchase of Ordinary shares into treasury

(1,540)

-

(2,872)

Net cash outflow from financing activities

(4,908)

(3,310)

(8,819)

Net decrease in cash and cash equivalents

(86)

(756)

(348)

​

​

​

​

Reconciliation of net cash flow to movements in cash and cash equivalents

​

​

​

Decrease in cash and cash equivalents as above

(82)

(756)

(348)

Net cash and cash equivalents at start of period

1,322

1,675

1,675

Effect of foreign exchange rate changes

8

(18)

(5)

Cash and cash equivalents at end of period

1,248

901

1,322

Notes to the Financial Statements

For the six months ended 30 September 2025

1.

Accounting policies - Basis of accounting

​

The condensed interim financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) 34 'Interim Financial Reporting', as adopted by the International Accounting Standards Board (IASB), and interpretations issued by the International Financial Reporting Interpretations Committee of the IASB (IFRIC). They have also been prepared using the same accounting policies applied for the year ended 31 March 2024 financial statements, which were prepared in accordance with International Financial Reporting Standards (IFRS) and received an unqualified audit report.

​

The financial statements have been prepared on a going concern basis. In accordance with the Financial Reporting Council's guidance on 'Going Concern and Liquidity Risk', the Directors have undertaken a review of the Company's assets which primarily consist of a diverse portfolio of listed equity shares and in most circumstances, are realisable within a very short timescale.

​

During the year to 31 March 2025, the Company cancelled its share premium account and transferred the proceeds to a newly created special reserve, which is distributable in nature.

 

2.

Taxation

​

The taxation charge for the period represents withholding tax suffered on overseas dividend income.

 

3.

Dividends

​

​

​

​

The following table shows the revenue for each period less the dividends declared in respect of the financial period to which they relate.  ​ ​ ​

​

​

​

​

​

​

​

Six months ended

Six months ended

Year ended

​

​

30 September 2025

30 September 2024

31 March 2025

​

​

ÂŁ'000

ÂŁ'000

ÂŁ'000

​

Revenue

3,808

3,371

6,097

​

Dividends declared

(2,716)A

(2,648)B

(5,947)C

​

​

1,092

723

150

​

A Dividends declared relate to first two interim dividends (3.40p and 3.45p) in respect of the financial year 2025/26. ​ ​ ​

​

B Dividends declared relate to first two interim dividends (3.20p each) in respect of the financial year 2024/25. ​ ​ ​

​

C Dividends declared relate to three interim dividends (9.60p each) and the final dividend (5.20p) in respect of the financial year 2024/25. ​ ​ ​

 

4.

Earnings per Ordinary share

​

​

​

​

​

Six months ended

Six months ended

Year ended

​

​

30 September 2025

30 September 2024

31 March 2025

​

​

ÂŁ'000

ÂŁ'000

ÂŁ'000

​

Returns are based on the following figures:

​

​

​

​

Revenue return

3,808

3,371

6,097

​

Capital return

11,702

3,721

3,453

​

Total return

15,510

7,092

9,550

​

​

​

​

​

​

Weighted average number of Ordinary shares in issue

39,829,099

41,369,542

41,196,795

 

5.

Net asset value per Ordinary share

​

​

​

​

The net asset value per Ordinary share and the net asset values attributable to Ordinary shareholders at the period end were as follows: ​ ​ ​

​

​

​

​

​

​

​

As at

As at

As at

​

​

30 September 2025

30 September 2024

31 March 2025

​

​

(unaudited)

(unaudited)

(audited)

​

Net assets per Condensed Balance Sheet (ÂŁ'000)

117,313

109,739

106,711

​

3.5% Cumulative Preference shares of ÂŁ1 each (ÂŁ'000)

(50)

(50)

(50)

​

Attributable net assets (ÂŁ'000)

117,263

109,689

106,661

​

Number of Ordinary shares in issue

39,645,242

41,369,542

40,214,596

​

Net asset value per Ordinary share (p)

295.78

265.14

265.23

​

​

​

​

​

​

The Company has a policy of calculating the net asset value per Ordinary share based on net assets less an amount due to holders of 3.5% Cumulative Preference shares of £1 each equating to £1 per share (£50,000), divided by the number of Ordinary shares in issue. ​ ​ ​

 

6.

Called up share capital ​ ​ ​ ​ ​ ​

​

​

30 September 2025 ​

30 September 2024 ​

31 March 2025 ​

​

​

Number

ÂŁ'000

Number

ÂŁ'000

Number

ÂŁ'000

​

Allotted, called up and fully paid Ordinary shares of 50 pence each:

​

​

​

​

​

​

Balance brought forward

40,214,596

20,107

41,369,542

20,684

41,369,542

20,684

​

Ordinary shares bought back

(569,354)

(285)

-

-

(1,154,946)

(577)

​

Balance carried forward

39,645,242

19,822

41,369,542

20,684

40,214,596

20,107

​

​

​

​

​

​

​

​

​

Treasury shares:

​

​

​

​

​

​

​

Balance brought forward

2,018,478

1,009

863,532

432

863,532

432

​

Ordinary shares bought back to treasury

569,354

285

-

-

1,154,946

577

​

Balance carried forward

2,587,832

1,294

863,532

432

2,018,478

1,009

​

​

​

​

​

​

​

​

​

Allotted, called up and fully paid 3.5% Cumulative Preference shares of ÂŁ1 each

​

​

​

​

​

​

​

Balance brought forward and carried forward

50,000

50

50,000

50

50,000

50

​

​

​

21,166

​

21,166

​

21,166

​

​

​

​

​

​

​

​

​

During the six months ended 30 September 2025, 569,354 (six months ended 30 September 2024 - nil; year ended 31 March 2025 - 1,154,946) Ordinary shares were bought back to treasury . ​ ​ ​ ​ ​ ​

 

7.

Capital reserve

​

The capital reserve reflected in the Condensed Balance Sheet at 30 September 2025 includes ÂŁ14,393,000 (September 2024 ÂŁ2,881,000; 31 March 2025 ÂŁ3,672,000) which relate to the revaluation of investments held at the reporting date. The balance relates to realised gains of ÂŁ23,824,000 (30 September 2024 - ÂŁ28,291,000; 31 March 2025 - ÂŁ24,383,000).

 

8.

Analysis of changes in financial liabilities ​ ​ ​

​

​

Six months ended

Six months ended

Year ended

​

​

30 September 2025

30 September 2024

31 March 2025

​

​

ÂŁ'000

ÂŁ'000

ÂŁ'000

​

Opening balance at 1 April

(18,975)

(18,963)

(18,963)

​

Other movementsA

(6)

(6)

(12)

​

Closing balance

(18,981)

(18,969)

(18,975)

​

A The other movements represent the amortisation of the loan arrangement fees. ​ ​ ​

​

​

​

​

​

On 3 May 2022, the Company entered into a five year £20 million loan facility with The Royal Bank of Scotland International Limited, London Branch. £10 million of the loan facility has been drawn down and fixed at an all-in interest rate of 3.903% until 30 April 2027. £9 million of the facility has been drawn down on a short-term basis at an all-in interest rate of 5.62%, maturing 20 October 2025.  ​ ​ ​

 

9.

Transactions with the Manager

​

The Company has an agreement with abrdn Fund Managers Limited ("aFML") for the provision of management, secretarial, accounting and administration services and for the carrying out of promotional activities in relation to the Company.

​

The management fee is based on 0.45% per annum up to ÂŁ100 million and 0.40% per annum over ÂŁ100 million, by reference to the net assets of the Company and including any borrowings up to a maximum of ÂŁ30 million, and excluding commonly managed funds, calculated monthly and paid quarterly. In addition, a further fee of ÂŁ120,000 per annum is charged for other services provided under the terms of the management agreement. The fees are allocated 40% to revenue and 60% to capital (31 March 2024 - 50% to revenue and 50% to capital). The agreement is terminable on not less than six months' notice. For the period 1 December 2023 to 30 May 2024, there was a management fee waiver in place as a result of the transaction with abrdn Smaller Companies Income Trust plc ("ASCI"). For this period the fee was calculated at 0.29% per annum of net assets up to ÂŁ100 million and 0.26% per annum of net assets over this threshold. After this waiver period ended the fee returned to the existing fee rates. Should the Company terminate the management agreement within three years of the date of the transaction with ASCI (ie before 1 December 2026), then the Company undertakes to repay all or a proportion of the management fees waived by the Manager based on the time elapsed since completion of the transaction.

​

The total of the fees paid and payable during the period to 30 September 2025 was ÂŁ350,000 (30 September 2024 - ÂŁ311,000; 31 March 2025 - ÂŁ653,000) and the balance due to aFML at the period end was ÂŁ350,000. (30 September 2024 - ÂŁ173,000; 31 March 2025 - ÂŁ341,000).

​

The management agreement with aFML also provides for the provision of promotional activities, which aFML has delegated to abrdn Investments Limited. The total fees paid and payable in relation to promotional activities were ÂŁ30,000 (30 September 2024 - ÂŁ27,000 31 March 2025 - ÂŁ55,000) and the balance due to aFML at the period end was ÂŁ30,000 (30 September 2024 - ÂŁ13,000; 31 March 2025 - ÂŁ15,000).

 

10.

Segmental information

​

For management purposes, the Company is organised into one main operating segment, which invests in equity securities and debt instruments. All of the Company's activities are interrelated, and each activity is dependent on the others. Accordingly, all significant operating decisions are based upon analysis of the Company as one segment. The financial results from this segment are equivalent to the financial statements of the Company as a whole.

 

11.

Fair value hierarchy ​ ​ ​ ​ ​ ​

​

IFRS 13 'Fair Value Measurement' requires an entity to classify fair value measurements using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The fair value hierarchy has the following levels: ​ ​ ​ ​ ​ ​

​

Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities; ​ ​ ​ ​ ​ ​

​

Level 2: inputs other than quoted prices included within Level 1 that are observable for the assets or liability, either directly (ie as prices) or indirectly (ie derived from prices); and ​ ​ ​ ​ ​ ​

​

Level 3: inputs for the asset or liability that are not based on observable market data (unobservable inputs). ​ ​ ​ ​ ​ ​

​

The financial assets and liabilities measured at fair value in the Condensed Balance Sheet are grouped into the fair value hierarchy as follows: ​ ​ ​ ​ ​ ​

​

​

​

​

​

​

​

​

​

​

​

​

Level 1

Level 2

Level 3

Total

​

At 30 September 2025

​

Note

ÂŁ'000

ÂŁ'000

ÂŁ'000

ÂŁ'000

Financial assets at fair value through profit or loss

​

​

​

​

​

​

Quoted investments

a)

134,735

-

-

134,735

​

Net fair value

​

134,735

-

-

134,735

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Level 1

Level 2

Level 3

Total

​

At 30 September 2024

​

Note

ÂŁ'000

ÂŁ'000

ÂŁ'000

ÂŁ'000

​

Financial assets at fair value through profit or loss

​

​

​

​

​

​

​

Quoted investments

a)

127,052

-

-

127,052

​

Net fair value

​

127,052

-

-

127,052

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Level 1

Level 2

Level 3

Total

​

At 31 March 2025

​

Note

ÂŁ'000

ÂŁ'000

ÂŁ'000

ÂŁ'000

​

Financial assets at fair value through profit or loss

​

​

​

​

​

​

Quoted investments

​

a)

123,343

-

-

123,343

​

Net fair value

​

123,343

-

-

123,343

​

​

​

a)

Quoted investments. The fair value of the Company's quoted investments has been determined by reference to their quoted bid prices at the reporting date. Quoted investments included in Fair Value Level 1 are actively traded on recognised stock exchanges. ​ ​ ​ ​ ​

 

12.

The financial information contained in this Half Yearly Financial Report does not constitute statutory accounts as defined in Sections 434 - 436 of the Companies Act 2006. The financial information for the six months ended 30 September 2025 and 30 September 2024 has not been reviewed or audited by the Company's independent auditor.

​

The information for the year ended 31 March 2025 has been extracted from the latest published audited financial statements which have been filed with the Registrar of Companies. The report of the independent auditor on those accounts contained no qualification or statement under Section 498 (2), (3) or (4) of the Companies Act 2006.

 

13.

This Half Yearly Financial Report was approved by the Board on 21 November 2025.

 

Alternative Performance Measures

Alternative performance measures are numerical measures of the Company's current, historical or future performance, financial position or cash flows, other than financial measures defined or specified in the applicable financial framework. The Company's applicable financial framework includes IAS and the AIC SORP. The Directors assess the Company's performance against a range of criteria which are viewed as particularly relevant for closed-end investment companies. ​ ​ ​

Discount to net asset value per Ordinary share ​ ​ ​

The difference between the share price and the net asset value per Ordinary share expressed as a percentage of the net asset value per Ordinary share. ​ ​ ​

​

​

​

​

​

​

30 September 2025

31 March 2025

NAV per Ordinary share (p)

a

295.78

265.23

Share price (p)

b

279.00

255.50

Discount

(a-b)/a

5.7%

3.7%

​

​

​

​

Dividend yield

​

​

​

The annual dividend divided by the share price, expressed as a percentage. ​ ​ ​

​

​

​

​

​

​

30 September 2025A

31 March 2025

Annual dividend per Ordinary share (p)

a

15.50

14.80

Share price (p)

b

279.00

255.50

Dividend yield

a/b

5.6%

5.8%

A The annual dividend yield is based on the first interim dividend of 3.40p, second and third interim dividends of 3.45p each and last year's final dividend of 5.20p. The final dividend for the year ending 31 March 2026 will be decided after the financial year end, following a review of the Company's earnings for the full year and outlook for the following year. ​ ​

​

​

​

​

Net gearing ​ ​ ​

Net gearing measures total borrowings less cash and cash equivalents divided by shareholders' funds, expressed as a percentage. Under AIC reporting guidance, cash and cash equivalents includes net amounts due to and from brokers at the period end as well as cash and short term deposits.  ​ ​ ​

​

​

​

​

​

​

30 September 2025

31 March 2025

Borrowings (ÂŁ'000)

a

18,981

18,975

Cash (ÂŁ'000)

b

1,248

1,322

Amounts due to brokers (ÂŁ'000)

c

-

-

Amounts due from brokers (ÂŁ'000)

d

-

-

Shareholders' funds (ÂŁ'000)

e

117,313

106,711

Net gearing

(a-b+c-d)/e

15.1%

16.5%

​

​

​

​

Ongoing charges ​ ​ ​

The ongoing charges ratio has been calculated in accordance with guidance issued by the AIC as the total of investment management fees and administrative expenses and expressed as a percentage of the average daily net asset values published throughout the year. The ratio for 30 September 2025 is based on forecast ongoing charges for the year ending 31 March 2026. ​ ​ ​

​

​

​

​

​

​

30 September 2025

31 March 2025

Investment management fees (ÂŁ'000)

​

708

653

Administrative expenses (ÂŁ'000)

​

468

447

Less: non-recurring chargesA(ÂŁ'000)

​

(8)

(6)

Ongoing charges (ÂŁ'000)

​

1,168

1,094

Average net assets (ÂŁ'000)

​

114,831

109,660

Ongoing charges ratio

​

1.02%

1.00%

A Comprises professional fees (31 March 2025 - promotional activities) not expected to recur. ​ ​ ​

​

​

​

​

Total return ​ ​ ​

NAV and share price total returns show how the NAV and share price has performed over a period of time in percentage terms, taking into account both capital returns and dividends paid to shareholders. Share price and NAV total returns are monitored against open-ended and closed-ended competitors, and the Benchmark, respectively.  ​ ​ ​

​

​

​

​

​

​

​

Share

Six months ended 30 September 2025

​

NAV

Price

Opening at 1 April 2025

a

265.23p

255.50p

Closing at 30 September 2025

b

295.78p

279.00p

Price movements

c=(b/a)-1

11.5%

9.2%

Dividend reinvestmentA

d

3.5%

3.5%

Total return

c+d

15.0%

12.7%

​

​

​

​

​

​

​

​

​

​

​

Share

Year ended 31 March 2025

​

NAV

Price

Opening at 1 April 2024

a

256.00p

222.00p

Closing at 31 March 2025

b

265.23p

255.50p

Price movements

c=(b/a)-1

3.6%

15.1%

Dividend reinvestmentA

d

5.8%

7.3%

Total return

c+d

9.4%

22.4%

A NAV total return involves investing the net dividend in the NAV of the Company with debt at fair value on the date on which that dividend goes ex-dividend. Share price total return involves reinvesting the net dividend in the share price of the Company on the date on which that dividend goes ex-dividend.  ​ ​ ​

 

Please note that past performance is not necessarily a guide to the future and that the value of investments and the income from them may fall as well as rise. Investors may not get back the amount they originally invested

 

By order of the Board

abrdn Holdings Limited

Company Secretary

21 November 2025

 

* Neither the Company's website nor the content of any website accessible from hyperlinks on the Company's website (or any other website) is (or is deemed to be) incorporated into, or forms (or is deemed to form) part of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR FEFFWFEISEDF
Date   Source Headline
13th Mar 202612:20 pmRNSNet Asset Value(s)
13th Mar 20268:45 amRNSPortfolio disclosure
13th Mar 20268:45 amRNSPortfolio disclosure
11th Mar 202611:59 amRNSNet Asset Value(s)
10th Mar 20265:21 pmRNSResults of Scheme Elections
10th Mar 20265:21 pmRNSResults of Scheme Elections
10th Mar 202611:34 amRNSNet Asset Value(s)
10th Mar 20267:30 amRNSSuspension - Shires Income Plc
10th Mar 20267:30 amRNSSuspension - Shires Income Plc
9th Mar 20262:56 pmRNSResult of First General Meeting and Class Meeting
9th Mar 20261:07 pmRNSGearing Disclosures
9th Mar 20261:07 pmRNSGearing Disclosures
9th Mar 202611:46 amRNSNet Asset Value(s)
6th Mar 202612:24 pmRNSNet Asset Value(s)
5th Mar 20262:00 pmRNSMonth End Net Asset Value(s)
5th Mar 202611:50 amRNSNet Asset Value(s)
4th Mar 202611:10 amRNSNet Asset Value(s)
3rd Mar 202610:50 amRNSNet Asset Value(s)
2nd Mar 20262:55 pmRNSGearing disclosure
27th Feb 202612:26 pmRNSNet Asset Value(s)
26th Feb 202612:25 pmRNSNet Asset Value(s)
25th Feb 202612:07 pmRNSNet Asset Value(s)
24th Feb 202611:57 amRNSNet Asset Value(s)
23rd Feb 202612:38 pmRNSGearing disclosure
23rd Feb 202612:05 pmRNSNet Asset Value(s)
20th Feb 202611:18 amRNSNet Asset Value(s)
19th Feb 202612:21 pmRNSNet Asset Value(s)
18th Feb 202611:00 amRNSNet Asset Value(s)
17th Feb 202610:32 amRNSNet Asset Value(s)
16th Feb 20261:40 pmRNSGearing disclosure
16th Feb 202612:20 pmRNSNet Asset Value(s)
16th Feb 20269:39 amRNSPortfolio disclosure
13th Feb 202612:39 pmRNSNet Asset Value(s)
12th Feb 202611:01 amRNSNet Asset Value(s)
11th Feb 202612:22 pmRNSNet Asset Value(s)
11th Feb 20267:01 amRNSPublication of Circular
11th Feb 20267:00 amRNSPre-liquidation Dividend
10th Feb 202612:14 pmRNSNet Asset Value(s)
9th Feb 20262:44 pmRNSGearing disclosure
9th Feb 20261:16 pmRNSNet Asset Value(s)
6th Feb 202611:20 amRNSNet Asset Value(s)
5th Feb 20262:00 pmRNSMonth End Net Asset Value(s)
5th Feb 202610:46 amRNSNet Asset Value(s)
4th Feb 202611:05 amRNSNet Asset Value(s)
3rd Feb 202612:45 pmRNSNet Asset Value(s)
2nd Feb 20264:11 pmRNSGearing disclosure
30th Jan 202612:19 pmRNSNet Asset Value(s)
29th Jan 202612:19 pmRNSNet Asset Value(s)
28th Jan 202611:35 amRNSNet Asset Value(s)
27th Jan 202611:46 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.